CytomX Therapeutics
CTMX
$1.89
Share price
-5.50%
Change (1 day)
6.78%
Change (1 year)
Categories
EPS for CytomX Therapeutics (CTMX)
EPS in 2023 (TTM): -$0.84
According to CytomX Therapeutics 's latest financial reports the company's current EPS (TTM) is -$0.84. In 2022 the company made an earnings per share (EPS) of -$1.71 an increase over its 2021 EPS that were of -$1.82.
EPS history for CytomX Therapeutics from 2015 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.84 | -50.88% |
| 2022 | -$1.71 | -6.04% |
| 2021 | -$1.82 | 30.94% |
| 2020 | -$1.39 | -52.56% |
| 2019 | -$2.93 | 45.05% |
| 2018 | -$2.02 | 72.65% |
| 2017 | -$1.17 | -27.78% |
| 2016 | -$1.62 | 35.65% |
| 2015 | -$1.19 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | 159.52% | 🇺🇸 USA |